Laboratory of Parasitology-Mycology (99UR/08-05), Department of Clinical Biology B, Faculty of Pharmacy, Monastir, Tunisia.
Diagn Microbiol Infect Dis. 2010 Oct;68(2):152-8. doi: 10.1016/j.diagmicrobio.2010.06.011.
Topoisomerase II gene of Leishmania genus was used to develop a molecular tool for detection and species differentiation of Leishmania from clinical samples. Identification was achieved by a polymerase chain reaction followed by digestion with 2 restriction endonucleases BstU1 and Taq1. Despite the relatively low sensitivity, it is able to differentiate between 3 complexes responsible for cutaneous leishmaniasis.
使用利什曼属拓扑异构酶 II 基因开发了一种分子工具,用于从临床样本中检测和区分利什曼原虫。通过聚合酶链反应(PCR)鉴定,并使用 2 种限制内切酶 BstU1 和 Taq1 进行消化。尽管灵敏度相对较低,但它能够区分引起皮肤利什曼病的 3 个复合物。
Diagn Microbiol Infect Dis. 2009-9-25
Trop Med Int Health. 2009-11
Clin Microbiol Rev. 2015-4
Emerg Infect Dis. 2014-3
PLoS Negl Trop Dis. 2012-6-19